Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
32
Number of overlapping holdings
82.1%
% of IHE's 35 holdings also in XPH
86.5%
% of XPH's 40 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 27.9% | 5.6% | 5.6% |
|
ZOETIS INC | 4.7% | 4.8% | 4.7% |
|
VIATRIS, INC. | 4.2% | 4.5% | 4.2% |
|
MERCK & CO. INC. | 4.2% | 4.2% | 4.2% |
|
JOHNSON & JOHNSON | 19.9% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to XPH
|
ELI LILLY & CO | 22.3% |
|
JOHNSON & JOHNSON | 15.9% |
|
AMICUS THERAPEUTICS INC | 1.2% |
|
MADRIGAL PHARMACEUTICALS, INC. | 0.8% |
|
CATALYST PHARMACEUTICAL PART | 0.4% |
|
IRONWOOD PHARMACEUTICALS INC | 0.4% |
|
VANDA PHARMACEUTICALS INC | 0.1% |
|
PHIBRO ANIMAL HEALTH CORP-A | 0.1% |
|
ATEA PHARMACEUTICALS, INC. | 0.1% |
|
MERCK & CO. INC. | 0.0% |
IHE Underweight Relative to XPH
|
REATA PHARMACEUTICALS, INC. CLASS A | -6.1% |
|
ELANCO ANIMAL HEALTH, INC. | -3.7% |
|
AXSOME THERAPEUTICS, INC. | -3.4% |
|
VENTYX BIOSCIENCES, INC. | -2.6% |
|
CATALENT INC | -2.3% |
|
CYMABAY THERAPEUTICS, INC. | -2.1% |
 |
PERRIGO CO | -2.1% |
|
ORGANON & CO. | -2.1% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.9% |
|
INTRA-CELLULAR THERAPIES INC | -1.8% |